News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
823,850 Results
Type
Article (76003)
Company Profile (467)
Press Release (747362)
Multimedia
Podcasts (176)
Webinars (27)
Section
Business (223404)
Career Advice (3046)
Deals (38550)
Drug Delivery (150)
Drug Development (89111)
Employer Resources (193)
FDA (18060)
Job Trends (16507)
News (381164)
Policy (37842)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2996)
Academic (1)
Accelerated approval (38)
Adcomms (36)
Allergies (161)
Alliances (55265)
ALS (188)
Alzheimer's disease (1823)
Antibody-drug conjugate (ADC) (363)
Approvals (18257)
Artificial intelligence (613)
Autoimmune disease (187)
Automation (46)
Bankruptcy (394)
Best Places to Work (12367)
BIOSECURE Act (23)
Biosimilars (210)
Biotechnology (297)
Bladder cancer (169)
Brain cancer (67)
Breast cancer (683)
Cancer (5236)
Cardiovascular disease (466)
Career advice (2586)
Career pathing (42)
CAR-T (314)
CDC (66)
Celiac Disease (2)
Cell therapy (842)
Cervical cancer (39)
Clinical research (75371)
Collaboration (1916)
Company closure (4)
Compensation (1221)
Complete response letters (78)
COVID-19 (2996)
CRISPR (106)
C-suite (947)
Cystic fibrosis (155)
Data (6567)
Decentralized trials (2)
Denatured (55)
Depression (158)
Diabetes (549)
Diagnostics (7208)
Digital health (51)
Diversity (12)
Diversity, equity & inclusion (47)
Drug discovery (295)
Drug pricing (227)
Drug shortages (34)
Duchenne muscular dystrophy (255)
Earnings (95532)
Editorial (69)
Employer branding (23)
Employer resources (166)
Events (129486)
Executive appointments (1064)
FDA (21378)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (12)
Frontotemporal dementia (25)
Funding (1608)
Gene editing (225)
Generative AI (52)
Gene therapy (691)
GLP-1 (1156)
Government (5279)
Grass and pollen (8)
Guidances (389)
Healthcare (20506)
HIV (73)
Huntington's disease (53)
IgA nephropathy (89)
Immunology and inflammation (306)
Immuno-oncology (73)
Indications (126)
Infectious disease (3309)
Inflammatory bowel disease (216)
Inflation Reduction Act (15)
Influenza (129)
Intellectual property (267)
Interviews (561)
IPO (17586)
IRA (58)
Job creations (4511)
Job search strategy (2130)
JPM (70)
Kidney cancer (18)
Labor market (93)
Layoffs (650)
Leadership (43)
Legal (9451)
Liver cancer (100)
Longevity (18)
Lung cancer (706)
Lymphoma (392)
Machine learning (45)
Management (64)
Manufacturing (890)
MASH (180)
Medical device (14772)
Medtech (14834)
Mergers & acquisitions (22068)
Metabolic disorders (1457)
mRNA (196)
Multiple sclerosis (176)
NASH (23)
Neurodegenerative disease (376)
Neuropsychiatric disorders (106)
Neuroscience (3217)
Neurotech (1)
NextGen: Class of 2026 (7315)
Non-profit (5053)
Now hiring (70)
Obesity (713)
Opinion (333)
Ovarian cancer (173)
Pain (224)
Pancreatic cancer (247)
Parkinson's disease (313)
Partnered (35)
Patents (540)
Patient recruitment (538)
Peanut (64)
People (64884)
Pharmaceutical (94)
Pharmacy benefit managers (34)
Phase 1 (23366)
Phase 2 (32848)
Phase 3 (24700)
Pipeline (5852)
Policy (348)
Postmarket research (3259)
Preclinical (10405)
Press Release (72)
Prostate cancer (266)
Psychedelics (60)
Radiopharmaceuticals (315)
Rare diseases (986)
Real estate (6958)
Recruiting (77)
Regulatory (28036)
Reports (60)
Research institute (2723)
Resumes & cover letters (486)
Rett syndrome (28)
RNA editing (20)
RSV (90)
Schizophrenia (165)
Series A (271)
Series B (203)
Service/supplier (20)
Sickle cell disease (109)
Special edition (28)
Spinal muscular atrophy (177)
Sponsored (49)
Startups (4115)
State (2)
Stomach cancer (21)
Supply chain (114)
Tariffs (101)
The Weekly (119)
Vaccines (1176)
Venture capital (101)
Weight loss (487)
Women's health (100)
Worklife (23)
Date
Today (229)
Last 7 days (876)
Last 30 days (2981)
Last 365 days (32076)
2026 (4964)
2025 (32291)
2024 (37428)
2023 (42273)
2022 (53660)
2021 (58387)
2020 (57172)
2019 (50405)
2018 (38236)
2017 (35981)
2016 (36635)
2015 (42744)
2014 (37292)
2013 (33438)
2012 (35214)
2011 (35440)
2010 (34486)
Location
Africa (1075)
Alabama (93)
Alaska (7)
Arizona (340)
Arkansas (14)
Asia (47582)
Australia (8179)
California (11995)
Canada (3408)
China (1211)
Colorado (502)
Connecticut (521)
Delaware (355)
Europe (109284)
Florida (1792)
Georgia (387)
Hawaii (4)
Idaho (66)
Illinois (963)
India (74)
Indiana (562)
Iowa (23)
Japan (457)
Kansas (132)
Kentucky (45)
Louisiana (29)
Maine (83)
Maryland (1486)
Massachusetts (8708)
Michigan (350)
Minnesota (668)
Mississippi (6)
Missouri (142)
Montana (36)
Nebraska (29)
Nevada (130)
New Hampshire (86)
New Jersey (3215)
New Mexico (33)
New York (3165)
North Carolina (1637)
North Dakota (10)
Northern California (5838)
Ohio (368)
Oklahoma (22)
Oregon (47)
Pennsylvania (2392)
Puerto Rico (25)
Rhode Island (49)
South America (1463)
South Carolina (70)
South Dakota (1)
Southern California (4655)
Tennessee (184)
Texas (1858)
United States (42911)
Utah (363)
Vermont (1)
Virginia (292)
Washington D.C. (88)
Washington State (979)
West Virginia (4)
Wisconsin (135)
Wyoming (2)
823,850 Results for "huntingdon s disease research group chdi foundation inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington’s Disease Research
May 28, 2025
·
4 min read
Press Releases
NeuraLight and CHDI Foundation Collaborate to Develop Precision Eye Movement Biomarkers for Huntington’s Disease
September 10, 2025
·
2 min read
Press Releases
Foundation for Sarcoidosis Research Receives 2025 RareVoice Award for Federal Advocacy During Rare Disease Month
February 23, 2026
·
3 min read
Business
Evotec and CHDI Foundation Extend Strategic Drug Discovery Collaboration in Huntington’s Disease
Evotec SE has announced the extension of its 20-year collaboration with CHDI Foundation, Inc. CHDI is a privately funded nonprofit biomedical research organisation exclusively dedicated to collaboratively developing therapeutics that will substantially improve the lives of those affected by Huntington’s disease.
May 28, 2024
·
5 min read
Press Releases
Nautilus Biotechnology and Weill Cornell Medicine-Qatar Collaborate with The Michael J. Fox Foundation to Advance Single-Molecule Proteomics Research in Parkinson’s Disease
January 29, 2026
·
7 min read
Press Releases
Hope Biosciences Research Foundation Reports Promising Phase II Trial Results for Stem Cell Therapy in Parkinson’s Disease
December 23, 2025
·
3 min read
Press Releases
Bay Area Lyme Foundation Highlights Research Leadership and Momentum in Tick-Borne Disease, Names New Executive Director
February 12, 2026
·
6 min read
IN PARTNERSHIP WITH TAKEDA
Takeda’s Commitment to Trial Representation is Shaping the Future of Clinical Research
One way Takeda lives out its values is by striving to ensure that patients are aware of and can access the company’s clinical trials. Two employees from its research and development organization discuss why representation matters and the work their team is doing to benefit patients now and in the future.
January 5, 2026
·
5 min read
·
BioSpace Insights
Press Releases
Allergy Research Group Announces Peer-Reviewed Publication Advancing Thyroid and Endocrine Integration Science
February 5, 2026
·
2 min read
Press Releases
The Mark Foundation and The Sontag Foundation Lead Coalition to Propel Novel Brain Tumor Therapy Research with $4 Million in New Grants
February 11, 2026
·
4 min read
1 of 82,385
Next
